Lantheus Holdings
-
GE Healthcare, Lantheus Phase III clinical trial finds radiotracer can improve detection of coronary artery disease
The Phase III Open-Label Study, which involved over 600 patients across sites in the US, Europe and Canada assessed the…
Read More »